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Purpose/Objective: Be able to know the real dosimetry inside the 
patients is very important to know the accuracy provided by the 
Treatment Planning Systems (TPS) and at the same time it is very 
difficult to realize. To evaluate the dosimetry in a realistic manner 
without resorting to a real patient, anthropomorphic phantoms can be 
used. . In this work, we have evaluated the calculations provided by 
the TPS Eclipse V10 with AAA algorithm in the pelvic area of a RANDO 
Man© anthropomorphic phantom for prostate treatments, assessing 
the measures through the use of termoluminiscent detectors (TLDs) 
with the data provided by the planner in PTVs as well as in various 
organs of risk.  
Materials and Methods: 4 prostate treatments, 2 low risk cases (PTV-
T to 7000cGy in 30 fractions) and 2 high risk cases with nodal chain 
irradiation (PTV-T to 7000cGy and PTV-N to 5040 in 30 fraction)) were 
planned using a Eclipse V10 with AAA algorithm and irradiated in a 
VARIAN 2300 iX linear accelerator, equipped with Millenium 120 MLC. 
PTVs and OARs were delineated in the previously scanned phantom. 
All treatment plans consisted of a single VMAT field, 6 MV X-rays, full 
rotation and 30º of collimator rotation. Dose was prescribed to the 
median PTV dose, requiring that more than 98% of the PTV volume 
should receive at least 95% of the prescribed dose, and no more than 
2% of the PTV volume should exceed 107% of the prescribed dose. 
Organs at risk fulfilled the departments’ constraints. A set of 100 TLDs 
(Harshaw XD-100 extremity (EXT-RAD) model) was used in order to 
calibrate, background measures, and PTVs and Organs At Risk (OARs) 
measurements.  
Results: The results of the TLDs dose measurements are summarized 
in the Table 1.And the absolute desviations for all the measurements 
is presented in Figure 1.Regarding with the high dose low gradient 
region, the average dose difference was -1.5% ± 4.6% (1 SD) for the 
PTV-T and -0.3% ± 4.5% for the PTV-N. The average OARs dose 
difference is below 2.5% for all of them. The standard deviation of the 
OARs is significantly higher than the corresponding to the PTVs. A 
plausible explanation is that the TLD have a size of about 3 mm, and 
are located in regions of high dose gradients. Also must be taken into 
account that small variations of the TLD position have a great impact 
on its dose measurement or calculation. Although the analysis done in 
this work was focused on the prostate, it is equally applicable to the 
rest of pathologies involved in the pelvis or abdominal area, because 
the type of heterogeneities is quite similar. 
 
Table 1: Number of measurements for each location and mean
result in %  
Location Number ofmeasurements 
Mean result (Dcalculated -
Dread)/Dread 
Rectum 10 -0.22% ± 9.7% 
Bladder 4 2.35% ± 3.6% 
Femoral Heads 16 -2.02% ± 6.4% 
Intestinal 
package 2 0.99% ± 8.7% 
PTV-T 11 -1.50% ± 4.6% 
PTV-N 6 -0.27% ± 4.5% 
 
 Conclusions: The use of TLD in conjunction with anthropomorphic 
phantoms is a useful tool to verify the accuracy of the dose 
calculation algorithm implemented in the TPS in realistic anatomical 
cases. We conclude that the AAA algorithm provides reliable dose 
calculation for the treatment with VMAT in the anatomy of the pelvis. 
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Purpose/Objective: Step 1 : To validate relative and absolute dose 
calculations of electron Monte Carlo algorithm (Eclipse, eMC 10.0.28, 
Varian) in simple geometry conditions for a set of inserts (rectangle, 
square) used in the clinical routine in a water phantom: profiles, 
percentage depth dose (pdd) and monitor units (MU) calculations. 
Step 2 : To study some dosimetric parameters of eMC calculations for 
boost dose in breast cancer: 1) validation of relative dose and MU 
calculations with obliquities in a water phantom and 2) comparison of 
MU calculated in Step 1 with 13 patient case studies ; first, with mass 
densities of the patients ; second, by assigning 0 UH to the 'body' not 
to take into account internal heterogeneities.  
Materials and Methods: Varian eMC modelling procedure was carried 
out for 7 energies (6MeV, 9MeV, 12MeV, 15MeV,16MeV, 18 MeV and 
20MeV) and 5 applicators (6x6cm2, 10x10cm2, 15x15cm2, 20x20cm2 and 
25x25cm2). Cylindrical and flat ionisation chambers (CC13, PPC40, 
NACP – IBA Dosimetry) were used for relative and absolute dose 
measurements in water. MU were calculated for delivering 1 Gy at the 
maximum depth dose on the beam axis. eMC calculations grid size and 
accuracy were 2 mm and 1%. In step 1, the gantry was perpendicular 
to the water phantom and the surface skin distances were 100cm, 
105cm and 110cm. 
Results: Step 1 : Relative dose measurements including profiles in the 
lateral constriction of 80% isodose curve gave good agreements with 
eMC calculations. The largest differences in pdd at 50% of the 
maximum dose were found at 6 MeV, up to 2.1 mm for a 5x10cm2 
rectangular inlay. Profiles fitted well with differences < 1% of the 
inlay size at 50% of the profile. The largest differences were found 
after the flat floor of the profile on the rounded part (between 98% 
and 90%). We achieved good agreement between MU eMC calculations 
and measurements, resulting in a maximum absolute deviation of 
3.8%, 2.2% and 1.9% respectively for energies of 6MeV, 9MeV and 
12MeV. Step 2 : Differences between MU eMC calculations in patients 
and MU calculated in water in step 1 were slightly higher, resulting 
respectively to 9.2%, 3.5% and 23.3% in mean, minimum and maximum 
deviations. These deviations remained similar when assigning 0 UH to 
the 'body' of the patients, resulting respectively to 8.1%, 3.5%, and 
21.6%.  
Conclusions: Step 1 : Relative and absolute dose measurements were 
found to be accurate enough for a clinical use of eMC. Step 2: 
significant differences were identified between UM measurements in 
water (step 1) and eMC calculations in patients both with mass 
densities of the patients or by assigning 0 UH to the 'body'. Beam 
obliquity relative to the patient surface was found to be one of the 
main parameter that could explain this deviation (as far as 
prescription point was at the maximum pdd in a soft tissue).  
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Purpose/Objective: Independent verification of the monitor unit (MU) 
calculation for radiotherapy is important to ensure the accuracy of 
the dose calculation in the treatment planning system (TPS). In2011, 
task group 114 (TG-114) of the American Association of Physicists in 
Medicine published a report for use as a guideline for verifying the MU 
calculation. We consider the clinical use of an independent MU 
calculation software (EqualDose v 4.0) that was developed by a 
project of the European Society for Radiotherapy and Oncology. We 
have evaluated the accuracy of dose calculation by this MU calculation 
software on the basis of the TG-114 report. 
Materials and Methods: Verification plans in a homogeneous phantom 
were modeled in the TPS (Xio, Elakta Oncology Systems and 
Eclipse,Varian Medical Systems), including open, physical wedge, 
dynamic wedge, and multi-leaf collimator fields. We selected an 
evaluation point within the phantom at the isocenter and off-axis 
point. Superposition (SP), Convolution (CO), Clarkson (CL), Analytical 
Anisotropic Algorithm (AAA), and Pencil Beam Convolution (PBC) 
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algorithms were used for the dose calculation of the TPS. Moreover, 
the pencil beam algorithm was used for the dose calculation in the MU 
calculation software. The prescribed dose was 200 MU for 6/10 MV 
photon beams (Trilogy, Varian Medical Systems). Dose measurements 
were performed using an ion chamber and a water phantom. 
Results: Figure 1 shows that the dose difference between the dose 
calculated by the MU calculation software and the measured dose for 
6/10 MV photon beams was -0.5 ± 0.5% and -0.6 ± 0.6%, with the 
largest dose difference being -1.8% and -1.9%, respectively.  
Table 1 shows that the dose differences between the doses calculated 
by the MU calculation software and the TPS were 0.3 ± 0.7% (SP), -0.1 
± 0.7% (CO), -0.1 ± 1.0% (CL), 0.3 ± 0.6% (AAA), and 0.4 ± 0.7% (PBC), 
with the largest dose difference being 2.4%, -3.0%, -4.3%, 1.9%, and 
2.5%, respectively. All dose differences exceeding ±3% were caused by 
the physical wedge.  
 Figure 1. Dose difference between measured doses and doses 
calculated by the MU calculation software. 
 
Table 1. Dose difference between the doses calculated by the MU 
calculation software and the TPS for homogeneous conditions. 
 
 
Conclusions: The dose calculated by the MU calculation software was 
in agreement with the measured dose within ±2%. Moreover, the doses 
calculated by the MU calculation software and TPS were in agreement 
within ±3%, except for the Clarkson algorithm. Although the dose 
difference exceeded ±3% in verification plans of a physical wedge, in 
all verification plans, the result of dose calculation by the MU 
calculation software was less than the action levels of TG-114. Use of 
the MU calculation software offered sufficient accuracy in dose 
calculation for verifying the MU calculation, and it is an effective 
method for clinical use.  
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Purpose/Objective: To model the electron beams of Elekta SLi 
accelerators with the Monte Carlo algorithm of the research version of 
the Pinnacle treatment planning system (Pinnacle version 9.100, 
Philips Healthcare). The other goals of this work are to determine the 
effort needed to adapt models to a specific machine and to determine 
the accuracy of the electron beam model in the research version of 
Pinnacle. 
Materials and Methods: Anextensive set of measured electron beam 
data of two Elekta SLi accelerators (PDD, profiles on various depths, 
and output factors, multiple energies and applicator sizes) was 
available from Institution 3, and beam models based on limited data 
were available from Institution 4 and 5. The Monte Carlo algorithm 
uses a forward modelling from the source to the fluence plane 
approach. First, a single new model was built from the data measured 
by Institution 3 and the existing models. Afterwards, output factors 
were calculated and the machine was commissioned. Then, the 
accuracy of the single model was evaluated. Secondly, by comparing 
the model with measurement data from Institution 1, it was tested 
which parameters of the model needed adaptation to adequately 
describe the beam data of institution 1. 
Results: Modeling took 3 days (due to calculation time) per energy 
with five applicator sizes. Calculation of output factors took about 
7days per energy at a machine with two AMD Opteron 254 processors 
and with 16 GB RAM. The measured data of institution 3 could be 
modeled with a single forward model for 9 and 12 MeV, resulting in a 
maximum of 3% deviation in PDD and profiles (according to Fig 1) for 
all applicator sizes (see Fig. 1A for 12 MeV, 10x10cm2 frame). For 6, 
15, 18 MeV a second model was required to reach this result. The 
comparison of the model with measured data from Institution 1 
resulted in small differences in PDD and profiles. Beam energy was 
somewhat higher in the model, and profiles were narrower (Fig 1B). 
Therefore,only small obvious changes were required to model the 
data of Institution 1 accurately (e.g. to account for a different field 
size definition (at 95 cm instead of 100 cm) and reference depth). 
Performing these changes of model took only 2 hours per energy. Fig. 
1C shows the model for Institution 1. 
 
Figure 1. PDD and X profiles at the depth of 1.9cm for 12MeV and 
10x10cm2 applicator. A: Data from Institution 3 (solid line) and 
corresponding model (dashed line). B: Institution 3 data (solid line) 
and adapted model for Institution 1 data (dashed line). C: Data from 
Institution1 (solid line) and corresponding model (dashed line). 
  
Conclusions: Starting from a set of electron beam models of similar 
machines, commissioning of Elekta SLi linacs in the Pinnacle 
treatment planning system is achievable in a limited amount of time 
by fitting specific calibration settings only. 
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Purpose/Objective: In the Philips Pinnacle treatment planning system 
v9.2 it is possible to interpolate the control points of a VMAT plan 
